Compound 18a5
Product Specifications
Bioactivity
Compound 18a5 was demonstrated to be a promising lead compound for the treatment of TNBC by degrading ANXA3.
Smiles
O=C(CSC(NC1C(N(C(C)C)C(C=CC=C2)=C2C(C3=CC=CC=C3)=N1)=O)=S)N(CC4)CCN4C5=NC=CC=C5
Molecular Formula
C30H32N6O2S2
Molecular Weight
572.74
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15157176 1 Vial
Lentiviral human MOB3C shRNA (UAS) - Lentiviral human MOB3C shRNA (UAS, RFP) (100)
Ask
View Details 
043372-ML750 100 µL
TSPAN1, ID (TSPAN1, Tetraspanin-1, Tetraspan NET-1, Tetraspanin TM4-C) (MaxLight 750) discontinued
Ask
View Details TA808925AM 100 µL
Bcl G (BCL2L14) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI6D1]
Ask
View Details